The indispensability of macrophage adaptor proteins in chronic inflammatory diseases
Copyright © 2023 Elsevier B.V. All rights reserved..
Adaptor proteins represent key signalling molecules involved in regulating immune responses. The host's innate immune system recognizes pathogens via various surface and intracellular receptors. Adaptor molecules are centrally involved in different receptor-mediated signalling pathways, acting as bridges between the receptors and other molecules. The presence of adaptors in major signalling pathways involved in the pathogenesis of various chronic inflammatory diseases has drawn attention toward the role of these proteins in such diseases. In this review, we summarize the importance and roles of different adaptor molecules in macrophage-mediated signalling in various chronic disease states. We highlight the mechanistic roles of adaptors and how they are involved in protein-protein interactions (PPI) via different domains to carry out signalling. Hence, we also provide insights into how targeting these adaptor proteins can be a good therapeutic strategy against various chronic inflammatory diseases.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:119 |
---|---|
Enthalten in: |
International immunopharmacology - 119(2023) vom: 05. Juni, Seite 110176 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Atre, Rajat [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adaptor Proteins, Signal Transducing |
---|
Anmerkungen: |
Date Completed 01.06.2023 Date Revised 01.06.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.intimp.2023.110176 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM356084949 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM356084949 | ||
003 | DE-627 | ||
005 | 20231226065716.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.intimp.2023.110176 |2 doi | |
028 | 5 | 2 | |a pubmed24n1186.xml |
035 | |a (DE-627)NLM356084949 | ||
035 | |a (NLM)37104916 | ||
035 | |a (PII)S1567-5769(23)00497-6 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Atre, Rajat |e verfasserin |4 aut | |
245 | 1 | 4 | |a The indispensability of macrophage adaptor proteins in chronic inflammatory diseases |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.06.2023 | ||
500 | |a Date Revised 01.06.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 Elsevier B.V. All rights reserved. | ||
520 | |a Adaptor proteins represent key signalling molecules involved in regulating immune responses. The host's innate immune system recognizes pathogens via various surface and intracellular receptors. Adaptor molecules are centrally involved in different receptor-mediated signalling pathways, acting as bridges between the receptors and other molecules. The presence of adaptors in major signalling pathways involved in the pathogenesis of various chronic inflammatory diseases has drawn attention toward the role of these proteins in such diseases. In this review, we summarize the importance and roles of different adaptor molecules in macrophage-mediated signalling in various chronic disease states. We highlight the mechanistic roles of adaptors and how they are involved in protein-protein interactions (PPI) via different domains to carry out signalling. Hence, we also provide insights into how targeting these adaptor proteins can be a good therapeutic strategy against various chronic inflammatory diseases | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Adaptor protein | |
650 | 4 | |a Inflammation | |
650 | 4 | |a Macrophage | |
650 | 4 | |a Protein-Protein Interactions | |
650 | 7 | |a Adaptor Proteins, Signal Transducing |2 NLM | |
700 | 1 | |a Sharma, Rahul |e verfasserin |4 aut | |
700 | 1 | |a Vadim, Gaponenko |e verfasserin |4 aut | |
700 | 1 | |a Solanki, Kundan |e verfasserin |4 aut | |
700 | 1 | |a Wadhonkar, Khandu |e verfasserin |4 aut | |
700 | 1 | |a Singh, Neha |e verfasserin |4 aut | |
700 | 1 | |a Patidar, Pramod |e verfasserin |4 aut | |
700 | 1 | |a Khabiya, Rakhi |e verfasserin |4 aut | |
700 | 1 | |a Samaur, Harshita |e verfasserin |4 aut | |
700 | 1 | |a Banerjee, Sreeparna |e verfasserin |4 aut | |
700 | 1 | |a Baig, Mirza S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t International immunopharmacology |d 2001 |g 119(2023) vom: 05. Juni, Seite 110176 |w (DE-627)NLM112639542 |x 1878-1705 |7 nnns |
773 | 1 | 8 | |g volume:119 |g year:2023 |g day:05 |g month:06 |g pages:110176 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.intimp.2023.110176 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 119 |j 2023 |b 05 |c 06 |h 110176 |